The publication of this infographic was funded by GSK. This content is intended for US Healthcare Professionals only.
Biologics targeting inflammatory pathways have revolutionized asthma treatment. However, adherence and persistence remain a challenge, and this may lead to some patients not receiving the full clinical benefit of their biologic therapy.
Topics covered:
- What real-world gaps are seen in treatment initiation among biologic-eligible patients?
- What adherence patterns are seen, including gaps or early/late stop?
- What is the relationship between persistence and exacerbations and oral corticosteroid (OCS) use?
- How do less frequent dosing intervals relate to initiating and staying on biologics?
